Seres Therapeutics' Series A Round

Seres Therapeutics raised a round of funding on November 21, 2013. Investors include Flagship Pioneering.

Seres Therapeutics is a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on novel scientific findings related to the human microbiome. The comp…

Articles about Seres Therapeutics' Series A Round: